In a matter involving an antitrust counterclaim, a generic pharmaceutical manufacturer alleged that a blockbuster brand manufacturer attempted to monopolize the market and delay entry of the generic product. A CRA expert was retained to analyze market definition, competitive effects, and lost profits damages estimates. The matter settled favorably for our client shortly before trial.
Dr. Alison Hole joins CRA's Antitrust & Competition Economics Practice
CRA is pleased to announce that Dr. Alison Hole has joined the company as a Vice President in the Antitrust & Competition Economics Practice.